Boston Pharmaceuticals
Dr. Sophie Kornowski was appointed Chief Executive Officer and Chair of the Board of Boston Pharmaceuticals in 2022. Since 2018, Sophie has been a partner at Gurnet Point Capital, a private investment firm focused on the healthcare sector. In this role, she worked closely with the Boston Pharmaceuticals team for several years, as a member of the Board of Directors and, at the request of the Board, has been supporting Corporate Development efforts.
In her position at Gurnet Point Capital, Dr. Kornowski has been a successful investor in several innovative start-ups and high-growth businesses that have products in the clinic or commercialize, diseases such as Attention Deficit Hyperactivity Disorder, Cancer, and Food Allergy.
This person is not in any offices
Boston Pharmaceuticals
Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives.